Intravesical therapy for urothelial carcinoma of the bladder

Murugesan Manoharan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.

Original languageEnglish
Pages (from-to)252-261
Number of pages10
JournalIndian Journal of Urology
Volume27
Issue number2
DOIs
StatePublished - Apr 1 2011

Fingerprint

Urinary Bladder
Carcinoma
Mycobacterium bovis
Urinary Bladder Neoplasms
Neoplasms
Therapeutics
Guidelines
Recurrence

Keywords

  • Bladder
  • cancer
  • chemotherapy
  • intravesical

ASJC Scopus subject areas

  • Urology

Cite this

Intravesical therapy for urothelial carcinoma of the bladder. / Manoharan, Murugesan.

In: Indian Journal of Urology, Vol. 27, No. 2, 01.04.2011, p. 252-261.

Research output: Contribution to journalArticle

Manoharan, Murugesan. / Intravesical therapy for urothelial carcinoma of the bladder. In: Indian Journal of Urology. 2011 ; Vol. 27, No. 2. pp. 252-261.
@article{eaa8c8e3fed7420dac021c9525bf1875,
title = "Intravesical therapy for urothelial carcinoma of the bladder",
abstract = "Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.",
keywords = "Bladder, cancer, chemotherapy, intravesical",
author = "Murugesan Manoharan",
year = "2011",
month = "4",
day = "1",
doi = "10.4103/0970-1591.82846",
language = "English",
volume = "27",
pages = "252--261",
journal = "Indian Journal of Urology",
issn = "0970-1591",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Intravesical therapy for urothelial carcinoma of the bladder

AU - Manoharan, Murugesan

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.

AB - Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.

KW - Bladder

KW - cancer

KW - chemotherapy

KW - intravesical

UR - http://www.scopus.com/inward/record.url?scp=79960664405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960664405&partnerID=8YFLogxK

U2 - 10.4103/0970-1591.82846

DO - 10.4103/0970-1591.82846

M3 - Article

C2 - 21814318

AN - SCOPUS:79960664405

VL - 27

SP - 252

EP - 261

JO - Indian Journal of Urology

JF - Indian Journal of Urology

SN - 0970-1591

IS - 2

ER -